Back to Search
Start Over
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.
- Source :
- Journal of Clinical Oncology; 7/1/2022, Vol. 40 Issue 19, p2138-2147, 10p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 40
- Issue :
- 19
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 157682206
- Full Text :
- https://doi.org/10.1200/JCO.21.02011